The SLC22A2 gene is a determinant of hematological toxicity of oxaliplatin in patients with colorect...
The SLC22A2 gene is a determinant of hematological toxicity of oxaliplatin in patients with colorectal cancer
About this item
Full title
Author / Creator
Chen, Jiayin , Wang, Li , Tong, Gangling , Ma, Jie , Liu, Chaoran and Wang, Lijun
Publisher
Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG
Journal title
Language
English
Formats
Publication information
Publisher
Germany: Dustri - Verlag Dr. Karl Feistle GmbH & Co. KG
Subjects
More information
Scope and Contents
Contents
To investigate the association between polymorphisms in the
gene and the hematological toxicity of oxaliplatin in colorectal cancer (CRC) patients receiving chemotherapy.
A total of 81 patients with colon or rectal cancer were included in the study. The single nucleotide polymorphisms (SNPs) rs3127573, rs316019, and rs1869641 of the
gene w...
Alternative Titles
Full title
The SLC22A2 gene is a determinant of hematological toxicity of oxaliplatin in patients with colorectal cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2839435226
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2839435226
Other Identifiers
ISSN
0946-1965
DOI
10.5414/CP204156
